/AVNS

Avanos Medical Inc

AVNS

$24.99USD↑+0.04%+0.01 today

MARKET CAP

1.2B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$25 – $25

52W RANGE

$9

$25

AI Summary

Stalk

StalkMedium

AVNS remains in a Stage 2 advancing trend with a bullish structural bias. A Devil’s Bargain continuation pattern suggests potential near-term upside extension, but current consolidation above flat EMAs and overbought RSI indicate a likely pause. Price is tightly tracking above the 9EMA and 20EMA, offering potential pullback entry zones. On balance, the medium-term bias is bullish, but execution should be deferred until a favorable pullback into support.

↑Specialty nutrition segment delivered 8% organic growth in 2025.
↑Nexus Medical integration adds ~$5M revenue targeting double-digit growth.
↓Tariffs impose ~$30M manufacturing costs in 2026, pressuring margins.

Full analysis →

Buying

8

institutions

Selling

4

institutions

New Positions

4

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	7.47 M	185.82 M	+625.06 K	+93.8%	0.00%
MM Millennium Management LLC Q2 2026	BUY	1.52 M	37.93 M	+1.51 M	+19482.1%	0.01%
JC Jpmorgan Chase & Co Q2 2026	BUY	1.10 M	27.42 M	+848.61 K	+695.1%	0.00%
PA Polar Asset Management Partners Inc. Q2 2026	BUYNEW	751.64 K	18.70 M	+751.64 K	+0.0%	0.39%
BA Balyasny Asset Management L.P. Q2 2026	BUYNEW	739.83 K	18.41 M	+739.83 K	+0.0%	0.02%
RT Renaissance Technologies LLC Q2 2026	BUYNEW	256.10 K	6.37 M	+256.10 K	+0.0%	0.01%
WP Woodline Partners LP Q2 2026	BUYNEW	236.90 K	5.89 M	+236.90 K	+0.0%	0.02%
AC Aqr Capital Management LLC Q2 2026	SELL	111.56 K	2.78 M	+-579.69 K	-71.1%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUY	41.41 K	580.21 K	+20.71 K	+149.6%	0.00%
TR T. Rowe Price Investment Management, Inc. Q2 2026	SELL	0.00	0.00	+-5.33 M	-100.0%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	0.00	0.00	+-489.70 K	-100.0%	0.00%
MC Moore Capital Management, LP Q2 2026	SELL	0.00	0.00	+-97.96 K	-100.0%	0.00%